Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 154 M159.4 M167.5 M186.9 M155.9 M 669.7 M Research & development ————— — Operating income 37.1 M67.3 M41.7 M-27.1 M-18.5 M 63.4 M Non-Operating Income, Total -400 K600 K-100 K900 K800 K 2.2 M Interest expense, net of interest capitalized 19.4 M18.9 M18.2 M17.6 M18.4 M 73.1 M Non-Operating Income, excl. Interest Expenses -19.4 M-18.9 M-18.2 M-17.8 M800 K -54.1 M Unusual income/expense -400 K600 K-100 K1.1 M— — Pretax income 17.3 M49 M23.4 M-43.4 M-36.1 M -7.1 M Equity in earnings ————— — Taxes 4 M11.7 M5.3 M-1.4 M-20.7 M -5.1 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 13.3 M37.3 M18.1 M-42 M-15.4 M -2 M Discontinued operations ————— — Net income 13.3 M37.3 M18.1 M-42 M-15.4 M -2 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 13.3 M37.3 M18.1 M-42 M-15.4 M -2 M Basic earnings per share (Basic EPS) 0.10.290.14-0.32-0.12 -0.01 Diluted earnings per share (Diluted EPS) 0.10.290.14-0.32-0.12 -0.01 Average basic shares outstanding 127.5 M126.8 M126.7 M127 M127.5 M — Diluted shares outstanding 130.7 M129.1 M129.5 M129.2 M127.5 M — EBITDA 60.4 M91.9 M65.6 M-35 M4.5 M 127 M EBIT 36.9 M67 M41.5 M-77.9 M-18.9 M 11.7 M Cost of revenue 458.1 M491.2 M480.7 M477.1 M461.4 M 1.91 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 23.5 M24.9 M24.1 M42.9 M23.4 M 115.3 M